Corporate Site
Skip to main content

Governance

Corporate Site

At QuidelOrtho, we are committed to conducting our business in accordance with all applicable laws, rules, and regulations, and the highest ethical standards. This section includes documents regarding the Company's corporate governance practices, evidencing the Company's commitment to sound principles of corporate governance.

Corporate Governance Documents

Download item year list
Download Description
Code of Business Conduct and Ethics (opens in new window)
Corporate Governance Guidelines (opens in new window)
Compliance Program (opens in new window)
California Transparency in Supply Chains Act Disclosure (opens in new window)
Conflict Minerals Policy (opens in new window)
Conflict Minerals Report (2021) (opens in new window)
Whistleblower Policy (opens in new window)

Committee Charters

Download item year list
Download Description
Audit Committee (opens in new window)
Compensation Committee (opens in new window)
Nominating and Corporate Governance Committee (opens in new window)
Science and Technology Committee (opens in new window)
Lead Independent Director (opens in new window)

QuidelOrtho’s Comprehensive Compliance Program, Code of Business Conduct and Ethics, and Annual Written Declaration may be obtained by calling 800-874-1517.

Board of directors

Douglas C. Bryant, Chairman and Chief Executive Officer of QuidelOrtho Corporation

Kenneth F. Buechler, Ph.D., Lead Independent Director
Founder and Former President, Chief Scientific Officer of Biosite, Inc.

Evelyn S. Dilsaver, Former President And CEO Of Charles Schwab Investment Management

Edward L. Michael, Managing Partner And Co-founder Of Lionbird Ventures
Former Executive Vice President, Diagnostic Products Of Abbott Laboratories

Mary Lake Polan, M.D., Ph.D., M.P.H., Professor of Clinical Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine

Ann D. Rhoads, Former Chief Financial Officer of Forty Seven, Inc.

Robert R. Schmidt, Managing Director Of The Carlyle Group

Christopher M. Smith, Chief Executive Officer At Neogenomics, Inc.
Former Chief Executive Officer And Chairman Of The Board Of Ortho Clinical Diagnostics Holdings Plc

Matthew W. Strobeck, Ph.D., Managing Partner of Birchview Capital

Kenneth J. Widder, M.D., Chief Executive Officer of Sydnexis Inc.

Joseph D. Wilkins Jr., Managing Director, JW Healthcare Insights
Former Executive Of Atlantic Health System, Quest Diagnostics, And Danaher-beckman Coulter

Stephen H. Wise, Managing Director And Global Head Of Healthcare Of The Carlyle Group

Committee Composition

Board Diversity Matrix

As of August 5, 2022

Total Number of Directors 12
  Female Male Non-Binary Did Not Disclose Gender
Part I: Gender Identity:
Directors 3 8 1
Part II: Demographic Background:
African American or Black 1
Alaskan Native or American Indian
Asian  1
Hispanic or Latinx
Native Hawaiian or Pacific Islander
White 2 7
Two or More Races or Ethnicities
LGBTQ+
Did Not Disclose Demographic Background 1

ANIMAL WELFARE

Quidel does not undertake any animal testing or outsource any animal testing to any third party.